Science Experimental Heart Drug Pelacarsen Fails Clinical Trial Despite Cutting Lp(a) Levels by 78% November 7, 2026 An experimental drug once hailed as a breakthrough in preventing heart attacks and strokes has failed a crucial clinical trial, despite successfully lowering a key blood protein linked to cardiovascular…
Health Hidden Liver Protein Controls Cholesterol and Heart Disease Risk May 25, 2026 Scientists Identify Master Switch for Cholesterol Control Researchers at UT Southwestern Medical Center identified a protein that acts as a key regulator. This protein controls how the liver releases cholesterol…